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Review
Murine hepatitis virus—A model for virus-induced
CNS demyelination
AE Matthews, SR Weiss, and Y Paterson
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Most murine hepatitis virus (MHV) strains, as their name suggests, infect the
liver.However,severalmurinestrainsaretropicforthecentralnervoussystem
(CNS) and cause encephalitis with subsequent CNS demyelination. The CNS
demyelination shares pathological similarities with human CNS demyelinat-
ing diseases such as multiple sclerosis (MS). These viruses are, therefore, used
to study the role of the immune system in viral clearance from the CNS, in CNS
demyelination, and in remyelination. Nevertheless, it is still unclear exactly
how MHV induces demyelination and to what extent the immune system plays
a role in this pathology. Here we review this ﬁeld in the context of the immune
response to MHV in the liver and the CNS focusing on studies that have been
published in the past 5 years. Journal of NeuroVirology (2002) 8, 76–85.
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Murine hepatitis virus: The encephalitogenic
murine coronavirus
Viral cell entry
Murine hepatitis virus (MHV) is a positive-strand
RNA coronavirus with a genome of approximately
31 kilobases (Holmes and Lai, 1996). The two strains
of MHV that have been used in the majority of studies
of MHV infection in the CNS are MHV-A59 and JHM
(MHV-4). These strains both infect mice; MHV-JHM
can also infect rats and primates (Murray et al, 1992).
MHV-A59 has approximately a 750-fold higher LD50
(3,000–5,000 pfu) (Lavi et al, 1986) than MHV-JHM
(1–10 pfu) when given intracerebrally (i.c.). Some at-
tenuated variants of MHV-JHM are less lethal and
cause minimal encephalitis (Wang et al, 1992). Both
viral strains express antigen primarily within spe-
ciﬁc areas of the brain, approximated by the limbic
system, but MHV-JHM antigen is also found loosely
scattered through the surrounding parenchyma (Lavi
et al, 1990; Sun and Perlman, 1995). The age of mice
at the time of MHV infection can affect the outcome
with increased viral replication and demyelination
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in weanling mice compared to adult mice (Weiner,
1973). Most studies are performed on 4- to 6-week-
old mice.
Both MHV-A59 and JHM infect, to some ex-
tent, oligodendrocytes, astrocytes (Lavi et al, 1987;
Stohlman et al, 1995a), neurons (Parra et al,
1997; Lavi et al, 1999), hepatocytes (Weiner, 1973;
Navas et al, 2001), macrophages, including Kuppfer
cells (Even et al, 1995; Stohlman et al, 1995a),
thymic epithelial cells (Knobler and Oldstone, 1987;
Godfraind et al, 1995), and the endothelial cells
which line blood vessels (Joseph et al, 1995; Lavi
et al, 1999). MHV-A59 has also been shown to in-
fect B cells (Coutelier et al, 1994), and MHV-JHM has
been detected in ependymal cells (Stohlman et al,
1995a). Except for glial cells and neurons, these cell
populations closely match those demonstrated to ex-
press the known MHV receptor Bgp1a (biliary glyco-
protein 1a), a member of the carcinoembryonic anti-
gen (CEA) family, which in turn is a member of the
immunoglobulin superfamily (Williams et al, 1991).
The Bgp1a receptor has been identiﬁed on hepato-
cytes, macrophages, epithelial cells (such as those in
the intestine), endothelial cells, B cells, and a small
proportion of thymic epithelial cells (Williams et al,
1991). A major determinant of tropism is the spike
(S) protein (Phillips et al, 1999; Navas et al, 2001),
suggesting that variations in MHV receptor (such
as posttranslational modiﬁcations or expression of
differentisoforms)mayaffectrecognitionbydifferent
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viruses. Expression of Bgp1a is very low in the CNS,
and the question of how virus enters glial cells and
neurons is still open.
Spread and kinetics of MHV infection
Infectious MHV can be found in astrocytes, oligo-
dendrocytes, and neurons after acute infection (Sun
and Perlman, 1995). Late after infection, virus is de-
tectable only as low levels of antigen or RNA (Lavi
et al, 1984b). In animals with viral persistence due to
the absence of IFN-γ, antigen is detected mainly in
oligodendrocytes (Parra et al, 1999). In mice infected
in the presence of protective maternal antibody, anti-
genpersistsinastrocytesaswellasotherunidentiﬁed
cells (Perlman and Ries, 1987). These studies demon-
strate that virus can persist in glial cells.
Afterintracerebral(i.c.)orintranasal(i.n.)infection
with MHV-A59, virus enters the brain and causes en-
cephalitis (Lavi et al, 1986). Intranasal infection with
MHV-JHM or -A59 leads to viral invasion through
the olfactory bulb and along olfactory tracts, as well
as a slower approach along the trigeminal nerve to
the mesencephalic nucleus (Lavi et al, 1986; Perlman
et al, 1989). Early spread of MHV-JHM and -A59 (up
to 4 d.p.i.) appears to be along speciﬁc neural path-
ways in the CNS (Perlman et al, 1989) and, therefore,
through neural connections. Later widespread infec-
tion can be blocked by passive transfer of antibody,
suggesting spread through the blood, cerebrospinal
ﬂuid, and/or interstitial ﬂuid (Perlman et al, 1989).
Liver infection can occur after any route of infec-
tion (i.n., i.c., i.g., or i.p.) with MHV-A59 (Lavi et al,
1986).MHV-A59livertiterspeak5dpiafteri.c.infec-
tion (Lavi et al, 1984b) and hepatitis develops during
the ﬁrst 1 to 2 weeks (Lavi et al, 1999). MHV-JHM
replicates transiently in the lungs, blood, and cervi-
cal lymph nodes after i.n. infection, and occasionally
is found in the thymus and bone marrow (Barthold
and Smith, 1992).
As would be expected in an infection that comes
under immunological control, viral titers peak
around 5 d.p.i. in the brain (Parra et al, 1997), slightly
later in the spinal cord (Matthews et al, 2001), and
virusisclearedby8–20d.p.i.(Sutherlandetal,1997).
The kinetics of viral antigen expression follow a pat-
tern similar to that observed of viral titers during
acute infection (Wang et al, 1992), but viral antigen
is still detectable up to 30 d.p.i. (Lavi et al, 1984a).
Viral RNA is detectable in the brain as late as 10–12
months postinfection, although the amount of RNA
decreases with time (Lavi et al, 1984a). However,
immunosuppression of cell-mediated immunity by
drugs,radiation,orT-celldepletionatlatetimepoints
after infection does not result in viral recrudescence
from this RNA pool (Stohlman and Weiner, 1981).
The immune response to MHV in the CNS
The blood–brain barrier is a major factor of the CNS
that limits immune function by preventing the easy
entryofserumantibodiesandinfectiousorganismsin
the absence of CNS inﬂammation (Cserr et al, 1992).
Although it has been thought that the blood–brain
barrier allows the entry of only activated T cells, a re-
cent study demonstrated that naive T cells can enter
the CNS if there are few activated T cells in circula-
tion (Brabb et al, 2000).
It has been suggested that immunosuppressive
cytokines such as transforming growth factor-beta,
alpha-melanocyte stimulating hormone, and inter-
leukin-10 (IL-10) may limit or alter immune func-
tion within the CNS (Gordon et al, 1998; Lipton and
Gonzales-Scarano, 1978). Work with T cells respond-
ing to Sindbis virus infection of the CNS demon-
strated that T cells lose their ability to proliferate
and down-regulate IL-2 production after entering
the brain, supporting the hypothesis that the envi-
ronment of the CNS alters immune function (Irani
etal,1997).Inaddition,thebrainfostersviralantigen
or nucleic acid persistence, which is not observed in
most peripheral organs and seems to be attributable
at least in some instances to inhibited immune-
mediated clearance (Kristensson and Norrby, 1986).
The poor regenerative potential of neurons and the
sensitivity of the CNS to small lesions may have con-
tributed to the development of a CNS environment
which downregulates the more destructive aspects
of the immune response.
The cells of the immune system successfully en-
ter the CNS after MHV infection. Mononuclear cells
of bone marrow origin peak 7 d.p.i. They then de-
cline, even in animals that do not control the infec-
tion (Williamson et al, 1991). In the absence of T cells
in nude mice, infectious MHV-JHM is not cleared
with normal kinetics (Houtman and Fleming, 1996),
demonstratingthatTcellsareimportantforclearance
of MHV.
CD8+ T cell response to MHV
CD8+ T cells are critical for the early control of MHV
infection in the CNS and for prevention of mortal-
ity (Gombold et al, 1995; Stohlman et al, 1995b;
Sutherland et al, 1997). Virus-speciﬁc CD8+ T cells
peak 7 days after MHV infection in the brain
(Williamson et al, 1991). The ability to detect MHV
speciﬁc CD8+ T cells in the draining cervical lymph
nodes (CLN) or the spleen varies (Bergmann et al,
1999; Parra et al, 1999). This variability may be
due to differences in the speciﬁc injection sites.
Virus delivered to the parenchyma results in a de-
layedperipheralimmuneresponsecomparedtovirus
delivered to the ventricles and cerebrospinal ﬂuid
(Stevenson et al, 1997).
CD8+ T cells recognize peptides presented on cell
surface MHC class I molecules. Although neurons
do not express MHC class I and therefore are not
anticipated targets of CD8+ T cells, MHC class I is
present on endothelial cells and microglia (Horwitz
et al, 1999). In addition, class I expression can be in-
ducedinastrocytesandoligodendrocytesincultureifP1: MRM
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exposed to factors secreted by cells infected with
MHV-A59 (Suzumura et al, 1986). After MHV-A59
infection of CD8+ T-cell-deﬁcient mice, viral anti-
gen clearance was delayed in microglia, lympho-
cytes, endothelial cells, and meningeal cells but not
in neurons or glia (Lavi et al, 1999). In another study,
transfer of CD8+ T cells suppressed MHV-JHM anti-
gen expression in astrocytes and microglia but not
oligodendrocytes (Stohlman et al, 1995a).
CD8+ T cells can function through the lytic
molecule perforin, through apoptosis induced by Fas
ligand (FasL), or by secreting cytokines such as IFN-
gamma and TNF-alpha (Kajino et al, 1998). All of
these mechanisms may be productively used in the
immune response to MHV. In the CNS of mice deﬁ-
cient for perforin, viral clearance is delayed, thereby
implicating a role for perforin in viral control (Lin
et al, 1997). Efﬁcient viral clearance in Fas-deﬁcient
mice demonstrated that FasL-mediated lysis is not
required for viral clearance. Nonetheless, mice lack-
ing both FasL-mediated apoptosis and perforin have
delayed clearance compared to mice just lacking per-
forin, suggesting that Fas-FasL interactions can con-
tribute to viral control although they may not be very
important (Parra et al, 2000).
Both CD4+ and CD8+ T cells persist in the CNS for
up to 34 d.p.i., with CD8+ T cells being more promi-
nent in the parenchyma both early and late after in-
fection (Stohlman et al, 1998a). The number of CD8+
T cells decreases with time and decreasing viral RNA
(Bergmann et al, 1999; Marten et al, 2000). At 45
d.p.i., about 48% of these cells are still virus-speciﬁc,
similar to the percentage of virus-speciﬁc T cells ob-
served during acute infection. Many of these chron-
ically present cells secrete IFN-gamma, but cytolytic
activity is gradually lost (Bergmann et al, 1999).
CD4+ T cell response to MHV
Although activated, MHV-speciﬁc, CD8+ T cells
transferred to infected mice can control viral replica-
tion, they are not sufﬁcient to clear infectious virus
from oligodendrocytes (Stohlman et al, 1998b). The
presence of CD4+ T cells is necessary for transferred
CD8+ T cell protection. Indeed, these cells appear to
be important for CD8+ T-cell lytic activity and sur-
vival in the CNS, perhaps through the secretion of
IL-2(Stohlmanetal,1998b).VirallyactivatedCD4+ T
cells protect against lethal viral infections after trans-
fer, but as with transferred CD8+ T cells, they are not
sufﬁcient to clear the virus (Stohlman et al, 1986).
Depletion of either CD8+ or CD4+ T cells results in
the inability of mice to control acute viral titers in the
brain(Williamsonetal,1990;Sutherlandetal,1997).
Thus, both CD4+ and CD8+ T cells are important for
control of acute viral infection in the CNS.
Unlike CD8+ T cells, which accumulate in
the parenchyma, CD4+ T cells tend to accumu-
late perivascularly and in subarachnoid spaces
(Stohlmanetal,1998a),locationsrichinMHCclass II
positive macrophages and microglia (Hickey and
Kimura, 1988; Braun et al, 1993). Interestingly, CD4+
T cell numbers peak in the CNS at 9 d.p.i., a little
later than CD8+ T cells (Williamson et al, 1991), and
persist in the CNS after viral clearance (Bergmann
et al, 1999; Marten et al, 2000).
Cytokine response to MHV
The effector function of many lymphocytes involves
the production and secretion of cytokines. mRNA
from a wide number of inﬂammatory cytokines can
be detected in the brain 3–7 days following i.c. infec-
tion with MHV-JHM. These include interferon (IFN)
alpha and beta (Wang et al, 1998), interleukin (IL)-1
alpha, IL-1 beta, IL-6, IL-2, and TNF-alpha (Parra
et al, 1997). Immunoﬂuorescence of MHV-JHM in-
fected spinal cords demonstrated the presence of
TNF-alpha protein as well as IL-1 beta and IL-6 in
cells with the morphology of macrophages early af-
ter infection and in uninfected astrocytes late after
infection (Sun et al, 1995).
Both Th1 (IFN-gamma) and Th2 (IL-4, IL-5, and
IL-10) cytokine mRNAs increase after infection with
various strains of MHV, peaking 7 to 9 days after
MHV-JHM infection (Stohlman et al, 1995a; Parra
et al, 1997). In several studies MHV infection re-
sulted in a predominantly IgG2a antibody isotype
proﬁle(Coutelieretal,1987;Flemingetal,1989)sup-
porting the idea of a predominantly Th1 response,
although in another study IgG2a did not predomi-
nate over IgG1 (Parra et al, 1997). These data, com-
bined with the presence of both Th1 and Th2 cy-
tokinemRNAs,suggestthatneitherT-helpercelltype
necessarily predominates, although a Th1 proﬁle is
slightly more common. MHV-JHM infection of mice
deﬁcient for IFN-gamma revealed that IFN-gamma
is not required for optimal antibody production or
for CTL responses. IFN-gamma is, however, neces-
sary for clearance of virus from the oligodendrocytes
(Parra et al, 1999). Clearance of an MHV strain that
primarily infects neurons is delayed in the absence of
IFN-gamma,suggestingthatitmayaffectviralcontrol
in other cell types as well without being absolutely
required for clearance (Lane et al, 1997). In mice deﬁ-
cient for IL-10, MHV-JHM causes a transient increase
in viral titers 7 d.p.i. and greater mortality than in
wild-type mice despite normal kinetics of viral clear-
ance, which is thought to be due to an increase in
inﬂammatory cytokines (Lin et al, 1998).
B cell response to MHV
The role of B cells in the control of MHV has been
studied in rats and mice. In Lewis rats, the transfer
of B cells into irradiated recipients decreased MHV-
JHM titers in the CNS (Schwender et al, 1999). IgM,
the ﬁrst detectable antibody isotype, ﬁrst appears
6 d.p.i. with MHV-JHM i.c. in mice (Stohlman et al,
1986; Williamson et al, 1991). Neutralizing antibod-
ies are detected in the serum by 9 d.p.i. with MHV-
JHM given i.c., but were not sufﬁcient to control vi-
ral titers within 11 d.p.i. in the absence of CD8+ TP1: MRM
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cells(Linetal,1997).Similarly,afterMHV-A59infec-
tion,serumantibodyisdetectable7d.p.i.andreaches
maximal levels 14–56 d.p.i. (Lavi et al, 1984b). By
electron microscopy, plasma cells can be observed in
the CNS as late as 90 d.p.i. with MHV-JHM(Stohlman
and Weiner, 1981). Antibody mostly of isotype IgG2a
is detected after infection (Lardans et al, 1996), al-
though sometimes IgG2a and IgG1 eventually reach
equivalent levels (Parra et al, 1997). Transfer of virus-
speciﬁc antibodies increases survival, presumably by
decreasing peak viral levels, delaying neuronal infec-
tion, and/or decreasing neuronal infection (Fleming
et al, 1989; Yokomori et al, 1992).
The contribution of humoral immunity to viral
clearance and persistent infection in the CNS has
beeninvestigatedusingmicedeﬁcientinsecretedan-
tibodies or B cells (Lin et al, 1999; Bergmann et al,
2001; Matthews et al, 2001). Mice homozygous for
disruptionoftheIgmugene(muMTmice)lackBcells
and develop acute disease in the CNS with similar ki-
netics and severity to wild-type C57BL/6 mice after
MHV-JHM infection (Lin et al, 1999) or MHV-A59 in-
fection (Matthews et al, 2001). Viral clearance during
acuteinfectionissimilarinbothgroups.However,al-
though virus is quickly cleared from the CNS of wild-
type mice, it reemerges and persists in the CNS of
muMT mice. B-cell-deﬁcient mice have been shown
to have impaired T cell immunity against a number
of viral infections including MHV-JHM (Bergmann
et al, 2001), possibly due to their absence as antigen-
presenting cells in these mice. To clarify how B
cells mediate viral clearance in the CNS, we com-
pared the role of B cells as antigen-presenting cells,
using mice with B cells that are unable to se-
crete antibody, with that of secreted antibody, using
muMT mice reconstituted with MHV-A59 immune
immunoglobulin (Matthews et al, 2001). muMT mice
that received A59-speciﬁc antibody had decreased
virus in the CNS, whereas mice with B cells deﬁ-
cient in antibody secretion did not clear virus from
the CNS. These data suggest a major role for im-
mune antibody in controlling virus replication in the
CNS.
Nonlymphocytic immune response to MHV
Natural killer (NK) cells (asialoGM1+ cells) peak in
the CNS at 7 days after i.c. inoculation with MHV-
JHM. The 7 d.p.i. CNS mononuclear cells are actively
cytotoxic on the classic NK target cell line YAC-1
when assayed ex vivo (Williamson et al, 1991). In
the absence of T cells, a transient decrease in viral
titers 5 to 7 d.p.i. has been attributed to the NK cell
response (Williamson et al, 1990). After immunosup-
pressionbycyclophosphamide,inmiceinfectedwith
a high dose of MHV-JHM, death occurs more quickly
(3 d.p.i.) than in untreated mice (6–7 d.p.i.) (Weiner,
1973). This observation suggests that the innate im-
mune response that expands in response to infection,
such as the NK cells, can be important in the early
control of viral infection.
Macrophages are susceptible to infection by MHV
(Wijburg et al, 1996), although only a subset is in-
fected initially. It has been proposed that CD4+ T
cells are necessary as a source of RANTES to at-
tract monocyte/macrophage inﬁltration of the CNS
(Lane et al, 2000). The role of macrophages in the
immune response is difﬁcult to pinpoint. Deple-
tion of blood-borne macrophages had little effect on
CNS demyelination (Xue et al, 1999). On the other
hand, depletion of macrophages before i.v. infection
with a highly lethal isolate of MHV-A59 resulted
in earlier mortality (3–5 d.p.i.) associated with in-
creased viral titers in the spleen and liver (Wijburg
et al, 1997). Macrophage depletion before i.n. in-
fection with MHV-JHM also resulted in rapid death
(Xue et al, 1999). The early time point of mortality
suggeststhatmacrophageshelpcontrolviraltitersbe-
fore the T and B cell populations are fully activated
and effective.
Immune response to MHV in the liver
The immune response that controls MHV infection
in the liver is similar in some ways to that impor-
tant in the CNS. Pre-existing antibody can protect
from lethal liver infections and decrease liver le-
sions, so antibody is capable of controlling liver viral
titers (Buchmeier et al, 1984). However in contrast to
the importance of antibody in controlling MHV-A59
replication in the CNS, antibody is not required for
viral clearance from the liver. In muMT mice, which
lack mature B lymphocytes, and in IgM-Tg mice with
B cells that do not secrete antibody, infectious virus
was cleared from the livers with similar kinetics to
wild-type mice after i.c. or i.h. infection (Matthews
et al, 2001).
Cell-mediated immunity is required for the con-
trol of infection in the liver. Depletion of CD4+ or
CD8+ T cells has been shown to result in increased
MHV-JHM titers in the liver and prolonged accumu-
lation of infectious virus to 5 d.p.i. When both T cell
populations were depleted, viral titers were not con-
trolled within 7 d.p.i., although the mice did sub-
sequently recover (Kyuwa et al, 1996). These data
suggest that T cells play a role in controlling vi-
ral titers, even before 5 d.p.i. Beta2-microglobulin-
deﬁcientmice,whichlackCD8+ Tcells,havedelayed
clearance of virus from the liver (Lavi et al, 1999).
IFN-gamma-deﬁcientmiceexperiencegreatermortal-
ity than do wild-type mice after i.p. infection with
MHV-JHM or MHV-A59 (Kyuwa et al, 1998; Schijns
et al, 1996). Virus persists up to 48 d.p.i. in the liver
and large lesions develop in these mice, although
there is no chronic increase in liver enzyme activ-
ity indicative of loss of liver function. Therefore,
IFN-gamma is critical for viral control in the liver.
In the absence of IFN-gamma, CD8+ T cell depletion
further increased the severity of disease (Kyuwa et al,
1998). Therefore, CD8+ T cell functions other thanP1: MRM
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IFN-gamma production are also important for viral
control.
MHV-induced CNS demyelination
CNS demyelination develops as active MHV-A59 or
MHV-JHM infection resolves. These lesions are his-
tologically very similar to those observed in MS pa-
tients. CNS lesions are predominantly created by
primary demyelination as evidenced by the intact,
naked axons present in these lesions, although ax-
onal damage is also detected (Lavi et al, 1986). The
peripheral nervous system is not affected (Lampert
et al, 1973). Lesions are scattered randomly through-
out the spinal cord (Lampert, 1978). Chronic lesions
are associated with lipid-laden macrophages (pre-
sumably full of myelin), scattered lymphocytes, and
naked axons. Viral particles are not detected. As-
trocytic reactions and perivascular cufﬁng are also
sometimes found in lesions (Weiner, 1973; Stohlman
and Weiner, 1981). Chronic lesions can persist as
late as 90 d.p.i. (Stohlman and Weiner, 1981), and
scattered demyelinated axons can be detected even
16 months after infection (Herndon et al, 1975).
Early demyelination after high-dose, lethal MHV-
JHM infection is associated with polymorphonuclear
cells, mononuclear cells, and extracellular myelin
debris. Degenerating axons are sometimes detectable
(Lampert et al, 1973). Nevertheless, even in necrotic
lesions formed during lethal infections, some axonal
preservation is observed (Weiner, 1973).
Chronic disease in MHV-infected animals is char-
acterized by a single major episode of demyelination
associated with the development of ataxia, hind limb
paresis, and paralysis (Lavi et al, 1984b), following
which animals usually recover. Recovery is mediated
by CNS remyelination, sometimes accompanied by
peripheral nervous system remyelination occurring
intheCNS(Takahashietal,1987).Remyelinationhas
been reported to begin anywhere from 14 to 70 d.p.i.
(KristenssonandNorrby,1986;Takahashietal,1987).
As early as 2 to 3 weeks postinfection, there is a dra-
matic increase in MBP mRNA at the edges of lesions
suggestive of early remyelination before histological
detection(KristenssonandNorrby,1986).At28d.p.i.,
replicating oligodendrocytes were detectable near le-
sions(Herndonetal,1977).Itisthoughtthatremyeli-
nation involves oligodendrocyte precursor O-2A cell
proliferation (Godfraind et al, 1989).
How does CNS demyelination occur? This is
perhaps the major question posed with the MHV
model of MS. Neither acute encephalitis nor RNA
persistence is sufﬁcient to cause demyelination,
as demonstrated with two mutants of MHV-A59
(Leparc-Goffart et al, 1998; Das Sarma et al, 2000).
Infectious virus does not have to be successfully
cleared for demyelination to occur (Houtman and
Fleming, 1996). Transfer of CD8+ T cells during acute
infection results in no subsequent demyelination,
although whether this treatment changes viral RNA
persistence is unclear (Stohlman et al, 1995a).
Early MHV-JHM-induced demyelination is rare in
immunodeﬁcient transgenic SCID and RAG1 knock-
out mice or irradiated mice, demonstrating a strong if
not absolute requirement for lymphocytes (Houtman
and Fleming, 1996; Wu and Perlman, 1999).
Electron micrographs of demyelinating lesions
demonstrate that macrophage processes slip be-
tween layers in the myelin sheath, suggesting that
macrophages could be the direct mediators of
demyelination (Powell and Lampert, 1975). Mac-
rophages localize to demyelinating lesions, and their
appearance correlates with the development of le-
sions. They do not appear in great numbers in the
absence of lymphocytes, consistent with the obser-
vation that lymphocytes are important for demyeli-
nation (Wu and Perlman, 1999; Lane et al, 2000). De-
spite the visual evidence that macrophages invade
myelin sheaths, it is possible that macrophages could
be localizing to areas of demyelination to clean up
the damaged myelin caused by a nonmacrophage
dependent mechanism. Depletion of blood-borne
macrophages does not affect the severity of demyeli-
nation, although similar techniques do affect de-
myelination in EAE and Theiler’s virus-induced de-
myelination (Huitinga et al, 1995; Rossi et al, 1997;
Xue et al, 1999). However, macrophages that are as-
sumed to be derived from microglia or perivascular
macrophagesarepresentintheCNSofthesedepleted
mice and may still play a role beyond that of scaveng-
ing for disintegrating myelin (Xue et al, 1999).
Tcellscouldmediatedemyelinationthroughdirect
lysis of oligodendrocytes or through inﬂammation
mediated by CD4+ T cell-dependent inﬂammation
as demonstrated in experimental autoimmune en-
cephalomyelitis. Certainly T cells persist in the CNS
aftervirusisclearedandduringactivedemyelination
(Marten et al, 2000). There is a signiﬁcant amount of
data demonstrating that neither CD4+ nor CD8+ T
cells are speciﬁcally required for demyelination. De-
myelination occurs during acute infection of T cell-
deﬁcient nude mice. Beta-2-microglobulin-deﬁcient
micecannotexpressMHCclassIandthereforedonot
developmatureCD8+ Tcells.I-Ab-deﬁcientmicelack
MHC class II and therefore do not develop mature
CD4+ T cells. Both of these strains of T cell-deﬁcient
mice demonstrate early MHV-JHM induced demyeli-
nation (Houtman and Fleming, 1996). Infection with
MHV-A59ofbeta-2microglobulin-deﬁcientmiceand
mice efﬁciently depleted of CD8+ T cells also re-
sults in demyelination, although less frequently than
in wild-type mice (Gombold et al, 1995; Sutherland
et al, 1997; Lavi et al, 1999).
Partial depletion of CD4+ and CD8+ T cells does
not inhibit chronic demyelination either, although
in this study T cells were not depleted until 7 d.p.i.
(Sutherland et al, 1997). A few studies suggested that
the absence of CD4+ or CD8+ T cells resulted in de-
ﬁcient demyelination. CD4+ or CD8+ T cell-deﬁcientP1: MRM
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mice infected with MHV-JHM were less likely to de-
velop acute demyelination, but the mice that did
develop demyelination had similar severity to that
observed in wild-type mice (Houtman and Fleming,
1996).CD4+ Tcell-deﬁcientmiceinfectedwithMHV-
JHM developed acute and chronic demyelination,
but it was signiﬁcantly less severe than that seen in
CD8 deﬁcient or wild-type mice (Lane et al, 2000).
When splenocytes were transferred to immunode-
ﬁcient RAG1 knockout mice, either CD4+ or CD8+
T cells were sufﬁcient to generate signiﬁcant levels
of acute demyelination, although CD4+ T cells were
less efﬁcient at inducing demyelination than CD8+
cells (Wu et al, 2000). These data suggest that each
of these T-cell subpopulations has the capability to
mediate CNS demyelination after MHV infection and
may induce slightly different levels or pathways of
demyelination. On the other hand we have observed
(Matthews et al, 2002) moderately sized, typical de-
myelinating lesions as well as atypical small round
necrotic lesions in MHV-A59 infected RAG1 knock-
out mice, suggesting that, although T cells may be re-
quired for robust demyelination, other mechanisms
must also be at work.
Knockout mice have been used to demonstrate
that the mechanism by which demyelination takes
place requires neither perforin nor Fas-FasL inter-
actions (Lin et al, 1997; Parra et al, 2000). Further-
more, removing TNF-alpha, IL-10, or IFN-gamma
through depletion or the use of genetically deﬁcient
micedidnotdecreasedemyelination(Stohlmanetal,
1995b;Linetal,1998;Parraetal,1999).Chemokines,
however, may play a role in demyelination. Gene
expression for a number of chemokines has been
found in the CNS of mice undergoing chronic de-
myelination (Lane et al, 1998). Of these the C-C
chemokine RANTES has been shown to possibly
play a role in MHV-induced demyelination (Lane
et al, 2000). Systemic depletion of RANTES with
RANTES-speciﬁc antisera resulted in a signiﬁcant re-
duction in macrophage inﬁltration and demyelina-
tion in C57BL/6 mice infected with MHV-4. RANTES
is a pro-inﬂammatory chemokine produced by T
cells, platelets, and endothelia that acts as a chemoat-
tractant for a variety of lymphocytic and myeloid
cell types including monocytes and granulocytes.
Lane and colleagues believe that the reduced de-
myelination observed in MHV-infected CD4−/− mice
may be due to the absence of CD4+ T cell-derived
RANTES (Lane et al, 2000). Thus, RANTES produced
by CD4+ T cells may attract macrophages into the
CNS during viral infection. Activated macrophages
are a potent source of toxic nitric oxide intermedi-
ates produced by inducible nitric oxide synthases
(iNOS). Inhibition of one of these, NOS-2, has been
shown to reduce MHV-induced demyelination (Lane
andBuchmeier,1999),providingfurtherevidencefor
a role for pro-inﬂammatory innate immune mecha-
nisms in CNS demyelination in this mouse model.
Among the CXC chemokines expressed in the CNS
during MHV-induced demyelinating disease is IFN-
inducible protein 10 (IP-10), suggesting a possible
role for this chemokine in demyelination (Lane et al,
1998). However, IP-10 has also been shown to be cru-
cial for control of MHV viral replication and recovery
from acute encephalitis in the C57BL/6 mouse (Liu
et al, 2000). Administration of anti-IP-10 antibody
led to a signiﬁcant reduction in T cells inﬁltrating
the CNS of MHV-infected mice, decreased levels of
IFN-γ in the CNS and increased mortality of infected
mice (Liu et al, 2000). Thus, although chemokine-
mediated inﬂammatory responses in the CNS may
contribute to demyelination, as with all immune re-
sponse elements examined, they also play a vital role
in viral clearance.
B cells and the antibodies they secrete could po-
tentially also mediate demyelination. However, no
correlation has been found in MHV-infected mice be-
tween antibody titers and severity of demyelination
(Koolen et al, 1987). In some animal models of CNS
demyelination,antibodiesagainstself-antigensinthe
brain induce or exacerbate demyelination (Brehm
et al, 1999; Genain et al, 1999) but there is no evi-
dence for the induction of antibodies that recognize
host proteins after MHV infection of the CNS. We
have examined the role of B cells in demyelination
using B cell-deﬁcient muMT mice (Matthews et al,
2002). In infected B cell-deﬁcient mice, robust de-
myelination not only occurred but was also statisti-
cally more severe than in wild-type animals 30 and
60 d.p.i. This increase in demyelination could be as-
sociated with the persistence of infectious virus in
the absence of B cells. In mice lacking antibody Fc
receptors or complement pathway activity, thereby
lacking the ability to utilize antibody effector func-
tions, virus did not persist yet demyelination was
similar to that observed in wild-type mice. Antibody
has also been suggested to facilitate remyelination.
However, in muMT mice, remyelination was still de-
tected. Therefore, we ﬁnd no evidence that B cells
are important for CNS demyelination, nor are they
required for remyelination.
Another hypothesis that has been proposed is that
MHV invades the oligodendrocytes or cells that pro-
vide critical functions to the oligodendrocyte and
damages them directly, thereby causing oligodendro-
cyte death or retraction of the myelin sheath. Early
work on MHV-JHM using electron microscopy and
immunoﬂourescence demonstrated that the virus in-
fects oligodendrocytes early and possibly late af-
ter infection, and thereby supported this hypothesis
(Lampert et al, 1973; Powell and Lampert, 1975; Wu
andPerlman,1999).However,thedegeneratingoligo-
dendrocytes detected during early paralysis rarely
actually contained viral particles (Powell and
Lampert, 1975). Viral particles were also detected in
astrocytes 7 d.p.i., and virus could potentially dam-
age oligodendrocytes by disrupting the function of
these cells (Sun and Perlman, 1995). Interestingly,
mice immunosuppressed using cyclophosphamideP1: MRM
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with resultant loss of antibody production and de-
creased perivascular inﬂammation still displayed
small demyelinating lesions (Weiner, 1973). Like-
wise, lipid-laden macrophages and occasional small
lesions were detected in RAG1 knockout mice (Wu
and Perlman, 1999), and SCID mice can develop de-
myelination, if rarely (Houtman and Fleming, 1996).
Direct virally mediated demyelination is unlikely to
be the sole cause of demyelination, however, because
virus in the presence of T cells more reliably induces
demyelinating lesions (Wang et al, 1992).
Conclusions
It is clear that demyelination after MHV infection is
a complex issue. It is possible that both direct viral
destruction and immune mediated destruction con-
tribute to the development of demyelinating lesions.
Past research has focused on dissecting the immune
response to MHV in order to determine the role of
single components in the demyelinating phase of the
disease. However, in contrast to other mouse models
of demyelination, there does not appear to be a clear
role for any one particular lymphocytic or monocytic
subset that mediates the demyelination. Rather, it ap-
pears that a balance of immune components may be
required for viral clearance and that various immune
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